Hopfield Jessica — SEC Form 4 filings
SEC reporting owner CIK 1648715. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-14 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 45,000 shares, $253,868 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 12,863 shares, $3,380,605 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 7,628 shares @ $225.26 ($1,718,283) in INSULET CORP, filed 2024-09-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INSULET CORP (PODD) | Director | 5 | — | 2 legs · 12,863 sh · $3,380,605 | 7 |
| Editas Medicine, Inc. (EDIT) | Director | 4 | 1 leg · 45,000 sh · $253,868 | — | 3 |
| MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Director | 2 | — | — | 2 |
Form 4 filings — Hopfield Jessica
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 51,700 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | INSULET CORP (PODD) | Grant/award (A): 1,660 @ $0 | EDGAR |
| 2025-06-18 | 4 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/award (A): 89,139 @ $2.16 | EDGAR |
| 2025-06-10 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | INSULET CORP (PODD) | Grant/award (A): 778 @ $0 | EDGAR |
| 2025-05-14 | 4 | INSULET CORP (PODD) | Option exercise (M): 5,235 @ $28.87 · Sale (S): 5,235 @ $317.54 · Option exercise (M): 5,235 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | INSULET CORP (PODD) | Option exercise (M): 7,628 @ $29.87 · Sale (S): 7,628 @ $225.26 · Option exercise (M): 7,628 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/award (A): 20,645 @ $10.78 | EDGAR |
| 2024-05-23 | 4 | INSULET CORP (PODD) | Grant/award (A): 1,380 @ $0 | EDGAR |
| 2024-05-14 | 4 | Editas Medicine, Inc. (EDIT) | Purchase (P): 45,000 @ $5.64 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1648715 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →